112 related articles for article (PubMed ID: 35201908)
1. Facilitators for use of oral healthcare services among people with substance use disorders: a qualitative study in Norway.
Carlsen SL; Isaksen K; Åstrøm AN; Fadnes LT
Acta Odontol Scand; 2022 Oct; 80(7):513-521. PubMed ID: 35201908
[TBL] [Abstract][Full Text] [Related]
2. Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals' experiences.
Carlsen SL; Isaksen K; Fadnes LT; Lygren OJS; Åstrøm AN
Subst Abuse Treat Prev Policy; 2021 May; 16(1):44. PubMed ID: 34001202
[TBL] [Abstract][Full Text] [Related]
3. Patient's and healthcare provider's experiences with Opioid Maintenance Treatment (OMT): a qualitative evidence synthesis.
Steiro A; Hestevik CH; Muller AE
BMC Health Serv Res; 2024 Mar; 24(1):333. PubMed ID: 38481254
[TBL] [Abstract][Full Text] [Related]
4. Stuck in limbo: illicit drug users' experiences with opioid maintenance treatment and the relation to recovery.
Grønnestad TE; Sagvaag H
Int J Qual Stud Health Well-being; 2016; 11():31992. PubMed ID: 27765141
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators for dental care among patients with severe or long-term mental illness.
Bjørkvik J; Henriquez Quintero DP; Vika ME; Nielsen GH; Virtanen JI
Scand J Caring Sci; 2022 Mar; 36(1):27-35. PubMed ID: 33523487
[TBL] [Abstract][Full Text] [Related]
6. Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study.
Skeie I; Brekke M; Clausen T; Gossop M; Lindbaek M; Reinertsen E; Thoresen M; Waal H
Eur Addict Res; 2013; 19(4):194-201. PubMed ID: 23257574
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study.
Bukten A; Skurtveit S; Waal H; Clausen T
Addict Behav; 2014 Oct; 39(10):1504-9. PubMed ID: 24960556
[TBL] [Abstract][Full Text] [Related]
8. The role of substance use and morality in violent crime - a qualitative study among imprisoned individuals in opioid maintenance treatment.
Havnes IA; Clausen T; Brux C; Middelthon AL
Harm Reduct J; 2014 Aug; 11():24. PubMed ID: 25142321
[TBL] [Abstract][Full Text] [Related]
9. Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study.
Gabrhelík R; Handal M; Mravčík V; Nechanská B; Tjagvad C; Thylstrup B; Hesse M; Minařík J; Jarkovský J; Bukten A; Clausen T; Skurtveit S
BMJ Open; 2021 May; 11(5):e047028. PubMed ID: 33972343
[TBL] [Abstract][Full Text] [Related]
10. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications.
Muller AE; Bjørnestad R; Clausen T
Drug Alcohol Depend; 2018 Jun; 187():22-28. PubMed ID: 29626742
[TBL] [Abstract][Full Text] [Related]
11. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
12. Acute pain management among patients with opioid maintenance therapy: specificities and difficulties identified in primary care: a qualitative study.
Guillou Landreat M; Baillot M; Le Goff D; Le Reste JY
BMJ Open; 2021 Jan; 11(1):e044433. PubMed ID: 33468504
[TBL] [Abstract][Full Text] [Related]
13. Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy.
Welle-Strand GK; Skurtveit S; Abel KF; Chalabianloo F; Sarfi M
J Subst Abuse Treat; 2020 Jun; 113():108004. PubMed ID: 32359675
[TBL] [Abstract][Full Text] [Related]
14. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
[TBL] [Abstract][Full Text] [Related]
15. Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway.
Karlstad Ø; Furu K; Skurtveit S; Selmer R
Eur Addict Res; 2014; 20(2):59-65. PubMed ID: 24080771
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug use among pregnant women in opioid Maintenance Treatment.
Lund IO; Skurtveit S; Engeland A; Furu K; Ravndal E; Handal M
Addiction; 2013 Feb; 108(2):367-76. PubMed ID: 22882166
[TBL] [Abstract][Full Text] [Related]
17. 'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'.
Havnes IA; Clausen T; Middelthon AL
Harm Reduct J; 2013 Oct; 10():24. PubMed ID: 24131626
[TBL] [Abstract][Full Text] [Related]
18. Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
Lugoboni F; Zamboni L; Mantovani E; Cibin M; Tamburin S;
Eur Addict Res; 2020; 26(4-5):263-273. PubMed ID: 31995807
[TBL] [Abstract][Full Text] [Related]
19. Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study.
Havnes I; Bukten A; Gossop M; Waal H; Stangeland P; Clausen T
Drug Alcohol Depend; 2012 Aug; 124(3):307-10. PubMed ID: 22382045
[TBL] [Abstract][Full Text] [Related]
20. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
Reimer J; Vogelmann T; Trümper D; Scherbaum N
Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
